)
Edge10 Jul 2026
Inside Take-Two: The Grand Anticipation
The story of how Take-Two Interactive built the empire behind Grand Theft Auto, Red Dead Redemption, and one of gaming's largest mobile portfolios.
Tempest Therapeutics
Tempest Therapeutics (TPST) investor relations material
Tempest Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary28 Jul, 2026
Executive summary
A special meeting of stockholders was convened to vote on amending the Restated Certificate of Incorporation to replace supermajority voting requirements and allow stockholder action by written consent.
67.7% of outstanding shares were represented, constituting a quorum, but not enough votes were received to approve the proposal.
The meeting was adjourned and will reconvene on August 17, 2026, to allow more time for voting and broader participation.
Voting matters and shareholder proposals
The main proposal seeks to amend the certificate to eliminate specified supermajority voting requirements and permit stockholder action by written consent.
Approval requires at least 75% of eligible votes.
No changes have been made to the proposal; proxies already submitted remain valid unless revoked.
Board of directors and corporate governance
Directors and executive officers are participating in the proxy solicitation process.
Information about directors, officers, and their stock ownership is available in recent SEC filings.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Tempest Therapeutics
- Proposal seeks to modernize governance by lowering voting thresholds and enabling written consent.TPST
Proxy filing17 Jul 2026 - Lead in vivo CAR-T asset targets broad autoimmune and oncology markets with scalable, modular delivery.TPSTCorporate presentation17 Jul 2026
- Proposal seeks to replace supermajority voting with majority standards and allow written consent.TPSTProxy filing7 Jul 2026
- Biotech registers 2.4M shares for resale; proceeds from warrant exercises fund operations.TPSTRegistration filing26 Jun 2026
- Amezalpat improved median OS by six months and doubled response rates in first-line HCC.TPSTStudy Update19 Jun 2026
- Approval sought for major warrant-related share issuances to support liquidity and Nasdaq compliance.TPSTProxy filing8 Jun 2026
- Shareholders to vote on major stock issuances tied to PIPE and Inducement Warrants, with Board support.TPSTProxy filing29 May 2026
- Q1 2026 saw a $27.7M net loss, $1.8M cash, and urgent financing needs amid pipeline progress.TPSTQ1 202614 May 2026
- TPST-2003 dual CAR-T achieves deep, durable responses and strong safety in rrMM, including EMD.TPSTCorporate presentation11 May 2026
Next Tempest Therapeutics earnings date
Q2 20267 Aug, 2026
Tempest Therapeutics
Next Tempest Therapeutics earnings date
Q2 20267 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage